11C-Glutamine

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Name11C-Glutamine

Drug Alias Name11C-Gln

ClassificationSmall molecules > Amino acid supplement, Lipids and VitaminsRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent

Mechanisms of ActionRadionuclide imaging enhancers

TargetsNot applicable

Therapy Area/IndicationsHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and Neck

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesThe University Of Texas MD Anderson Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe University Of Texas MD Anderson Cancer Center

Active IndicationsN/A

Inactive IndicationsHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and Neck

Other Information

ATC CodeN/A